Associations
newsletter
subscribe
advertise
contact
Technology
pulseTV
Buyer's Guide
Comparison Charts
Blogs
Events
Webinars
Magazine
Cardiac Diagnostics
ECG
ECG Management Systems
Holter Monitoring Systems
Stress Test Systems
Cardiac Imaging
Advanced Visualization
Angiography Systems
Cardiovascular Ultrasound
Contrast Media
CT Systems
Hybrid OR
MRI Systems
Nuclear Imaging
Cath Lab
Angiography Systems
Balloon Catheters
Hemostasis Management
Intravascular Imaging Systems
Interventional Radiology
Hybrid OR
Radial Access
Stents
Ventricular Assist Devices (VAD)
EP Lab
Ablation Systems
Cardiac Resynchronization Therapy Devices (CRT)
Implantable Cardioverter Defibrillators (ICD)
Leads, implantable devices
Pacemakers
Information Technology
Advanced Visualization
Cardiac PACS
Telecardiology
Structural Heart
Heart Valve Repair
Hybrid OR
Left Atrial Appendage (LAA) Occluders
Structural Heart Occluders/Closure Devices
C R Bard, Inc.
730 Central Avenue
Murray Hill
NJ
07974
USA
Phone:
800-367-2273
Fax:
908-277-8240
http://www.crbard.com
Related Articles
Balloon Catheter
Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial
Bard Completes Enrollment in IDE Drug-Coated Balloon Trial
Peripheral Arterial Disease (PAD) Treatment Devices
Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial
European Peripheral Vascular Device Market to Grow Strongly Through 2017
Drug-Eluting Balloons
Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial
Bard Completes Enrollment in IDE Drug-Coated Balloon Trial
Cath Lab
European Peripheral Vascular Device Market to Grow Strongly Through 2017
Clinical Trial/Study
Bard Completes Enrollment in IDE Drug-Coated Balloon Trial
Bard Receives FDA Approval for the LifeStent Peripheral Stent
Stents, Peripheral
Bard Receives FDA Approval for the LifeStent Peripheral Stent
Bard Receives FDA Clearance For E-Luminexx Vascular Stent
Bard Receives FDA Approval for Flair Endovascular Stent Graft
Bard Receives FDA Approval for Endovascular Stent Graft
Stent Grafts
Bard Receives FDA Approval for Flair Endovascular Stent Graft
Bard Receives FDA Approval for Endovascular Stent Graft
General Cardiology
Bard Receives FDA Approval for Flair Endovascular Stent Graft
Cardiology Products
Bard Receives FDA Approval for Flair Endovascular Stent Graft
Contrast Media Injectors
Marketing Agreement with Bard, Maximus Enhances CT Contrast Injection Catheters
CT Accessories/Services
Marketing Agreement with Bard, Maximus Enhances CT Contrast Injection Catheters